Matthew Lynn Matthew Lynn

The EU’s vaccine catastrophe is a crisis of its own making

As news emerges that both Pfizer and AstraZeneca are cutting supplies of their Covid-19 vaccines to the EU by up to 60 per cent, EU officials are turning on the drug companies, threatening fines and lawsuits if they don’t speed up deliveries. The Italian Prime Minister Giuseppe Conte has blasted the delays as unacceptable and threatened to take the companies to court. While the European Council President Charles Michel is threatening to use ‘all the legal means at our disposal’ to make the drugs companies ‘respect the contracts’ signed with the EU. But hold on, because on closer inspection it turns out that much of the unfolding vaccine catastrophe in the EU is of its own making.

The daily rankings of vaccination campaigns are making increasingly uncomfortable reading for most European countries. While Israel has managed to issue a remarkable 40 doses per 100 of its population, and Britain and the United States 9.3 and 6.2 respectively – with President Biden ramping up the American programme – the EU is stuck on a mere 1.9. Amid mounting and understandable criticism, it is promising to jab everyone by the summer. And yet, according to calculations by the website Politico, it will need a five-fold increase in its rate of vaccination to hit that target.

The blame game is already underway – and EU officials and politicians have clearly decided it is wicked Big Pharma that is at fault. Although there is not much evidence for that. To start with, the European Medicines Agency doesn’t seem to be in any great hurry to approve vaccines. It still hasn’t passed the Oxford jab, even though it is one of those that the EU has ordered in quantity. AstraZeneca is now likely to find itself in the slightly surreal position of being sued across Europe for not delivering enough of a vaccine that hasn’t even been authorised for sale.

Already a subscriber? Log in

Keep reading with a free trial

Subscribe and get your first month of online and app access for free. After that it’s just £1 a week.

There’s no commitment, you can cancel any time.

Or

Unlock more articles

REGISTER

Comments

Don't miss out

Join the conversation with other Spectator readers. Subscribe to leave a comment.

Already a subscriber? Log in